A child with generalized myasthenia gravis successfully treated with tacrolimus

No To Hattatsu

Volumn 39, Issue 4, 2007, Pages 300-303

  Goto, Tamako ^a   Mori, Masato ^a   Yamagata, Takanori ^a   Mizuguchi, Masashi ^a   Momoi, Mariko Y ^a  

^a Jichi University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; PREDNISOLONE; TACROLIMUS;

ARTICLE; CASE REPORT; CHILD; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG RESPONSE; FEMALE; HUMAN; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; PTOSIS; REMISSION; THYMECTOMY; UNSPECIFIED SIDE EFFECT;

CHILD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYASTHENIA GRAVIS; TACROLIMUS;

EID: 34547091922     PISSN: 00290831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Evoli A, Di Schino C, Marsili F, Punzi C. Successful treatment of myasthenia gravis with tacrolimus. Muscle Nerve 2002;25:111-4.
2. Japanese source
3. Konishi T, Yoshiyama Y, Takamori M, Saida T. Long-term treatment of generalized myasthenia gravis with FK506 (tacrolimus). J Neurol Neurosurg Psychiatry 2005;76:448-50.
4. Ponseti JM, Azem J, Fort JM, et al. Long-term results of tacrolimus in cyclosporine-and prednisone-dependent myasthenia gravis. Neurology 2005;64:1641-3.
5. Japanese source
6. Neuroimmunology 2000; 8:156-7.
7. Japanese source
8. Japanese source
9. http://www.fmu.ac.jp/home/neurol/guideline.html.
10. Gronseth GS, Barohn RJ. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:7-15.